SCHEMBL25840979

SCHEMBL25840979

CC1(C)CCN(C(=O)N2CCOCC2)CC1

nearest known ligand 0.67

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.57
TP53 P04637 1/20 0.57
KMT2A Q03164 1/20 0.57
MAPT P10636 1/20 0.53
RECQL P46063 1/20 0.50
POLB P06746 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
GAA P10253 1/20 0.48
ALDH1A1 P00352 2/20 0.48
AKR1C3 P42330 2/20 0.46
LMNA P02545 1/20 0.45
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA9 Q16790 1/20 0.43
TSHR P16473 1/20 0.43
HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4815349 0.92 MEN1 (0.53) MEN1TP53KMT2AMAPTRECQL
SCHEMBL4815339 0.92 MEN1 (0.53) MEN1TP53KMT2AMAPTRECQL
SCHEMBL28239649 0.87 ALDH1A1 (0.43) MEN1TP53KMT2AMAPTRECQL
SCHEMBL2899860 0.82 MEN1 (0.80) MEN1TP53KMT2AMAPTRECQL
SCHEMBL15451912 0.80 ALDH1A1 (0.56) MEN1TP53KMT2ASMN1; SMN2ALDH1A1
SCHEMBL17809482 0.80 ALDH1A1 (0.54) MEN1TP53KMT2ASMN1; SMN2ALDH1A1
SCHEMBL11741744 0.79 MEN1 (0.85) MEN1TP53KMT2AMAPTRECQL
Hydrochloric Acid SCHEMBL27660773 0.79 MEN1 (0.76) MEN1TP53KMT2AMAPTRECQL
Hydrochloric Acid SCHEMBL28000052 0.79 MEN1 (0.76) MEN1TP53KMT2AMAPTRECQL
SCHEMBL13450558 0.78 ALDH1A1 (0.61) MEN1TP53KMT2APOLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023116763-A1 PYRIDAZINE COMPOUND, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF 上海优理惠生医药有限公司 2023-06-29 WO disclosed